Share Email Print
cover

Proceedings Paper

Shining new light on treating dementia: integrating EEG neurofeedback training and near infrared photobiomodulation (Conference Presentation)
Author(s): Marvin H. Berman
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Evidence from animal and human studies regarding the biological impact of near infrared light stimulation has significantly increased of late noting the disease modifying properties of photobiomodulation for improving physical and cognitive performance in subjects with a variety of neurodegenerative conditions. Concurrently we see a growing body of literature regarding the efficacy of operant conditioning of EEG amplitude and connectivity in remediating both cognitive and behavioral symptoms of both neuropsychiatric and neurodegenerative disorders including traumatic brain injury, ADHD, PTSD, and dementia. This presentation seeks to outline a treatment model combining these two treatment methods to stop the progression of neurodegeneration using pulsed (10hz), brief (5-20minutes) repeated (1-2x/daily) transcranial and intranasal photobiomodulation with 810nm and 1068nm near infrared phototherapy and operant conditioning of EEG amplitude and coherence. Our initial study on treating dementia with EEG biofeedback (N=37) showed neuroplasticity's potential for modifying cognitive and behavioral symptoms using the evidence from decades of neurological research that never felt the warm touch of a translational researcher's hand. The near infrared interventional studies clarified the order of treatment, i.e., tissue health and renewal were achieved, followed by neural connectivity enhancement. Significant improvements in both immediate and delayed recall and praxis memory as well as executive functioning and behavioral regulation were obtained with each intervention. The inferred synergistic impact of properly combining these approaches is what informs our current clinical applications and future research efforts examining the value of combined treatments for all dementias, parkinson’s disease and age-related dry macular degeneration.

Paper Details

Date Published: 19 April 2017
PDF: 1 pages
Proc. SPIE 10048, Mechanisms of Photobiomodulation Therapy XII, 1004804 (19 April 2017); doi: 10.1117/12.2256941
Show Author Affiliations
Marvin H. Berman, Quietmind Foundation (United States)


Published in SPIE Proceedings Vol. 10048:
Mechanisms of Photobiomodulation Therapy XII
Michael R. Hamblin; James D. Carroll; Praveen Arany, Editor(s)

© SPIE. Terms of Use
Back to Top